Infiltrating T lymphocytes reduce myeloid phagocytosis activity in synucleinopathy model.

Szczegóły
Abstrakt

Tytuł:: Infiltrating T lymphocytes reduce myeloid phagocytosis activity in synucleinopathy model.
Autorzy:: Sommer A; IZKF Junior Research Group 3 and BMBF Research Group Neuroscience, Interdisciplinary Center for Clinical Research, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Glückstrasse 6, 91054, Erlangen, Germany.; Bavarian Research Network on Induced Pluripotent Stem Cells ('ForIPS'), Erlangen, Germany.
Fadler T; IZKF Junior Research Group 3 and BMBF Research Group Neuroscience, Interdisciplinary Center for Clinical Research, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Glückstrasse 6, 91054, Erlangen, Germany.
Dorfmeister E; IZKF Junior Research Group 3 and BMBF Research Group Neuroscience, Interdisciplinary Center for Clinical Research, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Glückstrasse 6, 91054, Erlangen, Germany.
Hoffmann AC; Institute of Biochemistry (Emil-Fischer-Center), FAU Erlangen-Nürnberg, Fahrstrasse 17, 91054, Erlangen, Germany.
Xiang W; Institute of Biochemistry (Emil-Fischer-Center), FAU Erlangen-Nürnberg, Fahrstrasse 17, 91054, Erlangen, Germany.
Winner B; IZKF Junior Research Group 3 and BMBF Research Group Neuroscience, Interdisciplinary Center for Clinical Research, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Glückstrasse 6, 91054, Erlangen, Germany.; Bavarian Research Network on Induced Pluripotent Stem Cells ('ForIPS'), Erlangen, Germany.; Institute of Human Genetics, FAU Erlangen-Nürnberg, Schwabachanlage 10, 91054, Erlangen, Germany.
Prots I; IZKF Junior Research Group 3 and BMBF Research Group Neuroscience, Interdisciplinary Center for Clinical Research, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Glückstrasse 6, 91054, Erlangen, Germany. .; Bavarian Research Network on Induced Pluripotent Stem Cells ('ForIPS'), Erlangen, Germany. .
Źródło:: Journal of neuroinflammation [J Neuroinflammation] 2016 Jun 30; Vol. 13 (1), pp. 174. Date of Electronic Publication: 2016 Jun 30.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
Język:: English
Imprint Name(s):: Original Publication: [London] : BioMed Central, c2004-
MeSH Terms:: Brain/*metabolism
Macrophages/*metabolism
Myeloid Cells/*metabolism
Phagocytosis/*physiology
T-Lymphocytes/*metabolism
alpha-Synuclein/*metabolism
Animals ; B-Lymphocytes/immunology ; B-Lymphocytes/metabolism ; B-Lymphocytes/pathology ; Brain/immunology ; Brain/pathology ; Humans ; Macrophages/immunology ; Macrophages/pathology ; Mice ; Mice, Transgenic ; Myeloid Cells/immunology ; Myeloid Cells/pathology ; T-Lymphocytes/immunology ; T-Lymphocytes/pathology ; alpha-Synuclein/immunology
References:: Parkinsonism Relat Disord. 2005 Dec;11(8):493-8. (PMID: 16154792)
Physiol Rev. 2011 Apr;91(2):461-553. (PMID: 21527731)
J Neuroinflammation. 2014 Jun 03;11:98. (PMID: 24889886)
Clin Neurosci Res. 2006 Dec 6;6(5):261-281. (PMID: 18060039)
J Neuroimmune Pharmacol. 2009 Dec;4(4):399-418. (PMID: 19655259)
J Parkinsons Dis. 2013;3(4):493-514. (PMID: 24275605)
Glia. 1988;1(5):301-7. (PMID: 2976393)
Nat Rev Neurosci. 2014 May;15(5):300-12. (PMID: 24713688)
Neuropathol Appl Neurobiol. 2013 Feb;39(1):3-18. (PMID: 23252647)
PLoS Med. 2009 Jul;6(7):e1000113. (PMID: 19636355)
J Neurosci Res. 2002 Jun 1;68(5):568-78. (PMID: 12111846)
J Neurosci. 2004 Oct 20;24(42):9434-40. (PMID: 15496679)
Arch Neurol. 2001 Oct;58(10):1580-3. (PMID: 11594915)
Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. (PMID: 22315722)
J Neuroimmune Pharmacol. 2009 Dec;4(4):462-75. (PMID: 19669892)
J Neuroinflammation. 2014 Jan 21;11:12. (PMID: 24447857)
Cell. 1992 Mar 6;68(5):855-67. (PMID: 1547487)
Ann Neurol. 2005 Feb;57(2):176-9. (PMID: 15668963)
Nat Rev Immunol. 2011 Oct 25;11(11):775-87. (PMID: 22025055)
Front Cell Neurosci. 2013 Apr 08;7:34. (PMID: 23596391)
J Immunol. 2013 May 15;190(10):5048-56. (PMID: 23589621)
J Neuroimmunol. 1990 May;27(2-3):229-37. (PMID: 2110186)
Nat Genet. 2010 Sep;42(9):781-5. (PMID: 20711177)
J Neuropathol Exp Neurol. 2008 Dec;67(12 ):1149-58. (PMID: 19018246)
Neurotherapeutics. 2012 Apr;9(2):297-314. (PMID: 22350713)
J Neural Transm (Vienna). 2010 Aug;117(8):961-70. (PMID: 20517700)
J Clin Invest. 2009 Jan;119(1):182-92. (PMID: 19104149)
Ann Neurol. 2003;53 Suppl 3:S49-58; discussion S58-60. (PMID: 12666098)
Neurology. 1988 Aug;38(8):1285-91. (PMID: 3399080)
J Neurosci Res. 2001 Jan 1;63(1):90-7. (PMID: 11169618)
Brain. 2009 Sep;132(Pt 9):2487-500. (PMID: 19531531)
Nat Neurosci. 2011 Sep 27;14(10):1227-35. (PMID: 21952260)
Nat Neurosci. 2014 Jan;17(1):131-43. (PMID: 24316888)
Trends Neurosci. 1996 Aug;19(8):312-8. (PMID: 8843599)
Antioxid Redox Signal. 2009 Sep;11(9):2151-66. (PMID: 19243239)
Int J Biochem Cell Biol. 2004 Aug;36(8):1374-9. (PMID: 15147715)
Front Cell Neurosci. 2014 Aug 04;8:211. (PMID: 25136294)
J Neurochem. 2015 Nov;135(3):589-97. (PMID: 26201615)
Neurobiol Aging. 2003 Mar-Apr;24(2):197-211. (PMID: 12498954)
J Neurosci. 2011 Aug 3;31(31):11159-71. (PMID: 21813677)
Ann N Y Acad Sci. 2003 Jun;991:214-28. (PMID: 12846989)
J Neuropathol Exp Neurol. 2004 Nov;63(11):1155-66. (PMID: 15581183)
Neuron. 2003 Sep 11;39(6):889-909. (PMID: 12971891)
Exp Neurol. 2012 Oct;237(2):318-34. (PMID: 22750327)
PLoS One. 2010 Jan 20;5(1):e8784. (PMID: 20098715)
Contributed Indexing:: Keywords: Adaptive immune system; Parkinson’s disease; Rag2; mThy1 WTS model
Substance Nomenclature:: 0 (SNCA protein, human)
0 (alpha-Synuclein)
Entry Date(s):: Date Created: 20160702 Date Completed: 20171010 Latest Revision: 20181113
Update Code:: 20240104
PubMed Central ID:: PMC4929755
DOI:: 10.1186/s12974-016-0632-5
PMID:: 27364890
: Czasopismo naukowe

Pełny tekst

Background: Synucleinopathies comprise a group of neurodegenerative diseases associated with abnormal accumulation of α-synuclein. One of the key factors that contribute to the progression of synucleinopathies is neuroinflammation. However, the role of lymphocytes in synucleinopathies like Parkinson's disease (PD) remains largely unclear.
Methods: To investigate how lymphocytes impact synucleinopathies, human wild-type α-synuclein (WTS) transgenic mice were crossed with mice lacking mature lymphocytes (Rag2(-/-)). In this in vivo model, we quantified α-synuclein aggregation in the substantia nigra (SN) and striatum and determined the numbers of innate and adaptive immune cells in the central nervous system (CNS). The activation state of resident and infiltrated CNS myeloid cells (M1 vs. M2) was further classified by gene and protein expression analyses. The impact of T and B lymphocytes on the phagocytic activity of microglia in the presence of α-synuclein aggregates was addressed in BV2 microglia in vitro.
Results: Compared to WTS(+) Rag2(+/+) mice, where T but not B lymphocytes infiltrated the CNS, decreased amounts of α-synuclein aggregates were found in WTS(+) Rag2(-/-) mice devoid of mature lymphocytes. The presence of T lymphocytes did not alter the number of Iba1(+) microglia but increased the frequency of the CD11b(+) CD45(hi) population in the CNS, indicative of an increased number of infiltrated macrophages. Moreover, the M1 phenotype was more prominent in WTS(+) Rag2(+/+) mice, whereas the M2 activation state was dominating in the absence of lymphocytes in WTS(+) Rag2(-/-) mice. In vitro, in the presence of T but not B lymphocytes, significantly less α-synuclein was phagocytosed by BV2 microglia, further supporting the prevalence of the M1 phenotype in the presence of T lymphocytes.
Conclusions: Peripheral T lymphocytes strongly contribute to increased α-synuclein pathology via modulation of CNS myeloid cell function. In the presence of T lymphocytes, microglia phagocytosis of aggregated α-synuclein is reduced, which increases the severity of synucleinopathy.

Informacja